Optiver Holding B.V. Candel Therapeutics, Inc. Transaction History
Optiver Holding B.V.
- $6 Billion
- Q3 2025
A detailed history of Optiver Holding B.V. transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 656 shares of CADL stock, worth $3,293. This represents 0.0% of its overall portfolio holdings.
Number of Shares
656Holding current value
$3,293% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CADL
# of Institutions
87Shares Held
15.6MCall Options Held
570KPut Options Held
203K-
Acorn Capital Advisors, LLC New York, NY2.58MShares$13 Million8.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.01MShares$10.1 Million0.0% of portfolio
-
Northpond Ventures, LLC1.94MShares$9.71 Million48.35% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.62MShares$8.14 Million0.59% of portfolio
-
Geode Capital Management, LLC Boston, MA928KShares$4.66 Million0.0% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $145M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...